---
title: "TLX: Strong imaging sales, new FDA approvals, and global trial progress drive growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299073100.md"
description: "A vertically integrated radiopharma company reported strong imaging sales and expanded its global infrastructure. Recent FDA approval of Pixclara opens a new market in glioma imaging, while the BiPASS and ProstACT GLOBAL 2 trials advance the pipeline in prostate cancer. U.S. trial recruitment and interim readouts are expected by early next year.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-15T15:37:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299073100.md)
  - [en](https://longbridge.com/en/news/299073100.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299073100.md)
generator: "portal-rs"
---

# TLX: Strong imaging sales, new FDA approvals, and global trial progress drive growth

A vertically integrated radiopharma company reported strong imaging sales and expanded its global infrastructure. Recent FDA approval of Pixclara opens a new market in glioma imaging, while the BiPASS and ProstACT GLOBAL 2 trials advance the pipeline in prostate cancer. U.S. trial recruitment and interim readouts are expected by early next year.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)

## Related News & Research

- [FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scans](https://longbridge.com/en/news/298841235.md)
- [Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58](https://longbridge.com/en/news/298970130.md)
- [Telix Pharmaceuticals (NASDAQ:TLX) Receives Outperform Rating from Wedbush](https://longbridge.com/en/news/298922533.md)
- [Morgan Stanley Remains a Buy on Telix Pharmaceuticals (TLPPF)](https://longbridge.com/en/news/298377353.md)
- [Telix opens radiopharmaceutical facility in Australia for cancer treatment](https://longbridge.com/en/news/292888971.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**